LONDON: A coalition seeking to get ahead of the next pandemic has agreed a US$34 million deal with German biotech CureVac to develop vaccine ...
LONDON: A coalition seeking to get ahead of the next pandemic has agreed a US$34 million deal with German biotech CureVac to develop vaccine"printing" technology that aims to rapidly produce shots against multiple diseases.
Epidemics of infectious diseases such as Ebola, Zika and Lassa can be unpredictable and fast-moving, yet developing vaccines against them can currently take 10 years or more. Under the three-year deal with CEPI, CureVac will use its mRNA platform to develop potential vaccines against Lassa Fever, Rabies and Yellow Fever.If preclinical tests for the three diseases are successful, two of the vaccine candidates will be developed through early stage safety trials in people.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Malaysia's Tan Chong Group to invest US$50 million in DanangDANAG, Vietnam: TCIE Vietnam Company, a member of Malaysia’s Tan Chong Motor Group, will build a new car factory in Hoa Khanh industrial zone ...
Read more »
Microsoft workers demand it drop US$450 million US Army contractSeveral Microsoft Corp employees on Friday demanded that the company cancel a US$480 million hardware contract with the U.S. Army and stop ...
Read more »
FCA to invest US$4.5 billion in Michigan to expand new Jeep SUV modelsFiat Chrysler Automobiles NV said on Tuesday it will invest US$4.5 billion in five plants and create 6,500 jobs in Michigan, including turning an ...
Read more »